BCLI - Brainstorm Cell Therapeutics, Inc.
IEX Last Trade
0.2983
-0.020 -6.772%
Share volume: 153,192
Last Updated: Fri 30 Aug 2024 09:36:52 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$0.32
-0.02
-6.34%
Summary score
23%
Profitability
25%
Dept financing
23%
Liquidity
43%
Performance
15%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Sep-2016 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-111.06%
Return on assets
-35.37%
Return on sales
0%
Return on invested capital
111.12%
Total debt ratio
71.93%
Debt ratio change over timeo
-0.61%
Current Ratio
3.55%
Quick Ratio
0%
Cash Position Ratio
1.19%
Short-term ratios 30-Sep-2019 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-29.92%
Return on assets
-53.88%
Return on sales
0%
Return on invested capital
108.07%
Total debt ratio
101.66%
Debt ratio change over timeo
0.48%
Current Ratio
2.16%
Quick Ratio
0%
Cash Position Ratio
1.69%
Last quarter ratios 30-Sep-2020
The data are presented for the financials results of the last quarter.
Return on equity
-17.28%
Return on assets
-13.72%
Return on sales
0%
Return on invested capital
110.13%
Total debt ratio
20.53%
Debt ratio change over time
-0.83%
Current Ratio
4.72%
Quick Ratio
0%
Cash Position Ratio
3.85%
Performance ratios (change over 4 years) 30-Sep-2016 - 30-Sep-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-152.03%
Return on assets
-121.87%
Return on sales
0%
Return on invested capital
-43.44%
Total debt ratio
-60.57%
Debt ratio change over time
-0.61%
Current Ratio
0.78%
Quick Ratio
0%
Cash Position Ratio
-0.67%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | BCLI | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -111.06% | -3.65% | 12.3% | 6.42% |
| Return on assets | -35.37% | 3.5% | 3.6% | 5.35% |
| Return on sales | 0% | 31.31% | 41.82% | 33.97% |
| Return on invested capital | 111.12% | 4.99% | 7.81% | 13.62% |
| Profitability | 25% | 36% | 69% | 61% |
| Total debt ratio | 71.93% | 101.15% | 75.51% | 29.75% |
| Debt ratio change over time | -0.61% | 224.03% | 6.03% | 1.46% |
| Dept financing | 18% | 50% | 19% | 8% |
| Current Ratio | 2.16% | 2.03% | 1.87% | 3.47% |
| Quick Ratio | 0% | 1.9% | 1.53% | 2.82% |
| Cash Position Ratio | 1.69% | 1.41% | 0.73% | 1.41% |
| Liquididy | 47% | 34% | 61% | 74% |
| Short-term ratios | BCLI | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -29.92% | -16.17% | 18.05% | 7.63% |
| Return on assets | -53.88% | 2.71% | 3.58% | 5.03% |
| Return on sales | 0% | 29.9% | 36.22% | 35.56% |
| Return on invested capital | 108.07% | 6.54% | 5.97% | 19.39% |
| Profitability | 25% | 36% | 69% | 65% |
| Total debt ratio | 101.66% | 99.31% | 83.77% | 30.59% |
| Debt ratio change over time | 0.48% | 851.68% | 10.97% | 0.58% |
| Dept financing | 25% | 49% | 21% | 8% |
| Current Ratio | 2.16% | 2.03% | 1.87% | 3.47% |
| Quick Ratio | 0% | 1.9% | 1.53% | 2.82% |
| Cash Position Ratio | 1.69% | 1.41% | 0.73% | 1.41% |
| Liquididy | 41% | 52% | 38% | 71% |